Article

STAAR initiatives aim to increase awareness of implantable contact lens

STAAR Surgical Co. is striving to increase consumer awareness of its implantable contact lens made of a proprietary material (Visian Implantable Collamer Lens).

Monrovia, CA-STAAR Surgical Co. has unveiled a redesigned Web site, revamped support for practices and distributors, and begun marketing to consumers in Asia in an effort to increase consumer awareness of its implantable contact lens made of a proprietary material (Visian Implantable Collamer Lens).

The lens “has proven to be a very effective alternative to LASIK, and these new programs are designed to educate consumers about the product line’s many benefits,” said Robin Hughes, vice president of global marketing for the company. “We already know from our work in search engine marketing that consumers are currently coming to us looking for alternatives, and we now have better resources to answer their questions and get them to the best local physicians who can help them. And, we are expanding this program globally.”

The redesigned Web site, www.visianinfo.com, launched June 28 and includes new product pages to inform patients about the implant. The site is designed to be easier to navigate, and its information is intended to be easy to understand.

The Web site also contains:

an enhanced surgeon locator, integrated with Google Maps;

a new blog featuring particular patients and practices monthly and including interviews and question-and-answer sessions with surgeons;

new testimonial pages;

a direct connection with the company's Facebook, Twitter, and YouTube pages; and

a new refractive options chart detailing ways to correct vision.

Practices and distributors developing their own consumer awareness campaigns will receive support from the new head of the company’s global online marketing as well as two new social media coordinators. Additional consumer marketing employees have been added in China, the Middle East, and India with expertise in direct-to-consumer education programming, and a new position will be added to execute social media work in Japan. The company continues to evaluate new consumer-driven initiatives by testing new methods to create consumer demand for individual practices.

“One current example of how we’re supporting practices is what we are doing for Dan Tran, MD, in southern California,” said Ryan Black, online marketing manager for STAAR. “This campaign is geared toward a certain segment of his patient base with the use of billboards-a traditional marketing tool-supported by online efforts and banner ads. It includes continuous testing of display ad effectiveness on the Google Ad Network, and early indications are we are succeeding."

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.